Pak Fah Yeow International Limited (0239.HK)
HKD 2.44
(0.41%)
HKD 2.44
(0.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 167.43 Million HKD | 126.09% |
| 2022 | 74.05 Million HKD | 7.77% |
| 2021 | 68.71 Million HKD | 65.67% |
| 2020 | 41.47 Million HKD | -46.31% |
| 2019 | 77.25 Million HKD | -30.32% |
| 2018 | 110.86 Million HKD | -23.46% |
| 2017 | 144.83 Million HKD | -1.57% |
| 2016 | 147.14 Million HKD | -1.15% |
| 2015 | 148.85 Million HKD | -1.56% |
| 2014 | 151.2 Million HKD | 24.24% |
| 2013 | 121.71 Million HKD | 23.5% |
| 2012 | 98.55 Million HKD | 15.67% |
| 2011 | 85.2 Million HKD | -1.07% |
| 2010 | 86.12 Million HKD | -0.96% |
| 2009 | 86.95 Million HKD | -4.32% |
| 2008 | 90.88 Million HKD | 11.71% |
| 2007 | 81.35 Million HKD | -1.53% |
| 2006 | 82.61 Million HKD | 7.37% |
| 2005 | 76.94 Million HKD | 4.82% |
| 2004 | 73.4 Million HKD | 1.68% |
| 2003 | 72.19 Million HKD | 3.03% |
| 2002 | 70.07 Million HKD | 11.44% |
| 2001 | 62.88 Million HKD | -11.89% |
| 2000 | 71.36 Million HKD | -4.72% |
| 1999 | 74.89 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 114.96 Million HKD | 0.0% |
| 2023 FY | 167.43 Million HKD | 126.09% |
| 2023 Q4 | 87.32 Million HKD | 0.0% |
| 2023 Q2 | 80.11 Million HKD | 0.0% |
| 2022 FY | 74.05 Million HKD | 7.77% |
| 2022 Q2 | 26.03 Million HKD | 0.0% |
| 2022 Q4 | 48.02 Million HKD | 0.0% |
| 2021 Q2 | 25.3 Million HKD | 0.0% |
| 2021 Q4 | 43.41 Million HKD | 0.0% |
| 2021 FY | 68.71 Million HKD | 65.67% |
| 2020 Q4 | 25.5 Million HKD | 0.0% |
| 2020 FY | 41.47 Million HKD | -46.31% |
| 2020 Q2 | 15.97 Million HKD | 0.0% |
| 2019 Q4 | 34.96 Million HKD | 0.0% |
| 2019 FY | 77.25 Million HKD | -30.32% |
| 2019 Q2 | 42.28 Million HKD | 0.0% |
| 2018 FY | 110.86 Million HKD | -23.46% |
| 2018 Q4 | 73.3 Million HKD | 0.0% |
| 2018 Q2 | 37.56 Million HKD | 0.0% |
| 2017 FY | 144.83 Million HKD | -1.57% |
| 2017 Q2 | 65.23 Million HKD | 0.0% |
| 2017 Q4 | 79.59 Million HKD | 0.0% |
| 2016 Q2 | 64.21 Million HKD | 0.0% |
| 2016 Q4 | 82.93 Million HKD | 0.0% |
| 2016 FY | 147.14 Million HKD | -1.15% |
| 2015 Q2 | 74.95 Million HKD | 0.0% |
| 2015 Q4 | 73.89 Million HKD | 0.0% |
| 2015 FY | 148.85 Million HKD | -1.56% |
| 2014 Q4 | 84.84 Million HKD | 0.0% |
| 2014 FY | 151.2 Million HKD | 24.24% |
| 2014 Q2 | 66.36 Million HKD | 0.0% |
| 2013 FY | 121.71 Million HKD | 23.5% |
| 2013 Q4 | 60.47 Million HKD | 0.0% |
| 2013 Q2 | 61.24 Million HKD | 0.0% |
| 2012 Q1 | 24.63 Million HKD | 0.0% |
| 2012 FY | 98.55 Million HKD | 15.67% |
| 2012 Q2 | 24.63 Million HKD | 0.0% |
| 2012 Q4 | 31.29 Million HKD | 27.0% |
| 2012 Q3 | 24.63 Million HKD | 0.0% |
| 2011 Q2 | 21.3 Million HKD | 0.0% |
| 2011 Q4 | 24.63 Million HKD | 15.67% |
| 2011 Q3 | 21.3 Million HKD | 0.0% |
| 2011 Q1 | 21.3 Million HKD | 0.0% |
| 2011 FY | 85.2 Million HKD | -1.07% |
| 2010 Q3 | 21.53 Million HKD | 0.0% |
| 2010 Q2 | 21.53 Million HKD | 0.0% |
| 2010 Q4 | 21.3 Million HKD | -1.07% |
| 2010 FY | 86.12 Million HKD | -0.96% |
| 2010 Q1 | 21.53 Million HKD | 0.0% |
| 2009 Q4 | 21.53 Million HKD | -0.96% |
| 2009 FY | 86.95 Million HKD | -4.32% |
| 2009 Q1 | 21.73 Million HKD | 0.0% |
| 2009 Q2 | 21.73 Million HKD | 0.0% |
| 2009 Q3 | 21.73 Million HKD | 0.0% |
| 2008 Q2 | 22.72 Million HKD | 0.0% |
| 2008 Q3 | 22.72 Million HKD | 0.0% |
| 2008 Q4 | 21.73 Million HKD | -4.32% |
| 2008 FY | 90.88 Million HKD | 11.71% |
| 2008 Q1 | 22.72 Million HKD | 0.0% |
| 2007 Q3 | 20.33 Million HKD | 0.0% |
| 2007 Q1 | 20.33 Million HKD | 0.0% |
| 2007 FY | 81.35 Million HKD | -1.53% |
| 2007 Q2 | 20.33 Million HKD | 0.0% |
| 2007 Q4 | 22.72 Million HKD | 11.71% |
| 2006 Q3 | 20.65 Million HKD | 0.0% |
| 2006 Q1 | 20.65 Million HKD | 0.0% |
| 2006 Q2 | 20.65 Million HKD | 0.0% |
| 2006 Q4 | 20.33 Million HKD | -1.53% |
| 2006 FY | 82.61 Million HKD | 7.37% |
| 2005 Q4 | 20.65 Million HKD | 7.37% |
| 2005 FY | 76.94 Million HKD | 4.82% |
| 2005 Q3 | 19.23 Million HKD | 0.0% |
| 2005 Q2 | 19.23 Million HKD | 0.0% |
| 2005 Q1 | 19.23 Million HKD | 0.0% |
| 2004 Q1 | 18.35 Million HKD | -0.0% |
| 2004 FY | 73.4 Million HKD | 1.68% |
| 2004 Q4 | 19.23 Million HKD | 4.82% |
| 2004 Q3 | 18.35 Million HKD | -0.0% |
| 2004 Q2 | 18.35 Million HKD | 0.0% |
| 2003 Q4 | 18.35 Million HKD | 1.68% |
| 2003 FY | 72.19 Million HKD | 3.03% |
| 2003 Q1 | 18.04 Million HKD | 0.0% |
| 2003 Q2 | 18.04 Million HKD | 0.0% |
| 2003 Q3 | 18.04 Million HKD | 0.0% |
| 2002 Q3 | 17.51 Million HKD | 0.0% |
| 2002 Q4 | 18.04 Million HKD | 3.03% |
| 2002 Q2 | 17.51 Million HKD | 0.0% |
| 2002 Q1 | 17.51 Million HKD | 0.0% |
| 2002 FY | 70.07 Million HKD | 11.44% |
| 2001 Q4 | 17.51 Million HKD | 11.44% |
| 2001 Q3 | 15.72 Million HKD | -0.0% |
| 2001 Q2 | 15.72 Million HKD | 0.0% |
| 2001 FY | 62.88 Million HKD | -11.89% |
| 2001 Q1 | 15.72 Million HKD | -0.0% |
| 2000 Q1 | 17.84 Million HKD | 0.0% |
| 2000 Q4 | 15.72 Million HKD | -11.89% |
| 2000 Q3 | 17.84 Million HKD | 0.0% |
| 2000 Q2 | 17.84 Million HKD | 0.0% |
| 2000 FY | 71.36 Million HKD | -4.72% |
| 1999 FY | 74.89 Million HKD | 0.0% |
| 1999 Q2 | 18.72 Million HKD | 0.0% |
| 1999 Q1 | 18.72 Million HKD | 0.0% |
| 1999 Q4 | 17.84 Million HKD | -4.72% |
| 1999 Q3 | 18.72 Million HKD | 0.0% |
| 1998 Q4 | 18.72 Million HKD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 97.434% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -481.799% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | 57.591% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 570.286% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | 69.629% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | 89.123% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | 64.473% |
| PuraPharm Corporation Limited | 216.62 Million HKD | 22.708% |
| SSY Group Limited | 3.48 Billion HKD | 95.201% |
| JBM (Healthcare) Limited | 319.41 Million HKD | 47.581% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | 73.015% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 99.614% |